caffeic acid has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukasawa, M; Hanada, K; Inamori, Y; Shirasago, Y; Sugiyama, K; Suzuki, T; Tanida, I; Wakita, T | 1 |
Daneshtalab, M; Hattori, M; Ma, CM; Wang, LN; Wang, W | 1 |
2 other study(ies) available for caffeic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid.
Topics: Antiviral Agents; Apolipoproteins E; Caffeic Acids; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; RNA, Viral; Tannins | 2019 |
Synthesis, Anti-HCV, Antioxidant and Reduction of Intracellular Reactive Oxygen Species Generation of a Chlorogenic Acid Analogue with an Amide Bond Replacing the Ester Bond.
Topics: Amides; Antioxidants; Caffeic Acids; Chlorogenic Acid; Esters; Hepatitis C; Humans; Oxidative Stress; Quinic Acid; Reactive Oxygen Species; tert-Butylhydroperoxide | 2016 |